These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11578417)
1. 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. Hoskins PJ; Swenerton KD; Manji M; Wong F; O'Reilly SE; McMurtrie EJ; Le N; Acker B; Le Richer J Int J Gynecol Cancer; 1994 Jul; 4(4):272-278. PubMed ID: 11578417 [TBL] [Abstract][Full Text] [Related]
2. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Firat S; Murray K; Erickson B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234 [TBL] [Abstract][Full Text] [Related]
3. Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). Hoskins PJ; Swenerton KD; Wong F; Manji MF; McMurtrie EM; Le N; Pike J Int J Gynecol Cancer; 1995 Mar; 5(2):134-142. PubMed ID: 11578468 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543 [TBL] [Abstract][Full Text] [Related]
6. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial. Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116 [TBL] [Abstract][Full Text] [Related]
7. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T; Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913 [TBL] [Abstract][Full Text] [Related]
8. A phase II trial of adjuvant cisplatin and doxorubicin in stage I epithelial ovarian cancer. Dottino PR; Plaxe SC; Cohen CJ Gynecol Oncol; 1991 Dec; 43(3):203-5. PubMed ID: 1752488 [TBL] [Abstract][Full Text] [Related]
9. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235 [TBL] [Abstract][Full Text] [Related]
13. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392 [TBL] [Abstract][Full Text] [Related]
14. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Veras E; Deavers MT; Silva EG; Malpica A Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant whole abdominal radiotherapy in epithelial cancer of the ovary. Hepp R; Baeza MR; Olfos P; Suarez E Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):360-5. PubMed ID: 12023140 [TBL] [Abstract][Full Text] [Related]
16. Experience of a 2-day BEP regimen in postsurgical adjuvant chemotherapy of ovarian germ cell tumors. Tay SK; Tan LK Int J Gynecol Cancer; 2000 Jan; 10(1):13-18. PubMed ID: 11240646 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma. Komaki R; Cox JD; Hartz AJ; Wilson JF; Mattingly R Cancer; 1986 Aug; 58(4):873-9. PubMed ID: 3719554 [TBL] [Abstract][Full Text] [Related]
18. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983 [TBL] [Abstract][Full Text] [Related]
19. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335 [TBL] [Abstract][Full Text] [Related]
20. Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. Schray MF; Martinez A; Howes AE; Podratz KC; Ballon SC; Malkasian GD; Sikic BI J Clin Oncol; 1988 Sep; 6(9):1433-9. PubMed ID: 3418375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]